Histological behavior of glutaraldehyde cross-linked bovine collagen injected into the human bladder for the treatment of vesicoureteral reflux.
Endoscopic subureteral collagen injection has become an accepted means for the treatment of vesicoureteral reflux in children. The aim of this study was to evaluate the histological behavior of glutaraldehyde cross-linked bovine collagen implants. The specimens were harvested from 29 patients who underwent reimplant surgery 2 to 30 months (mean 9.5) after unsuccessful subureteral injection therapy. In addition to routine hematoxylin and eosin staining, a new staining method (solophenyl red 3BL) able to demonstrate selectively neoformation of types I and III human collagen, was applied. Invasion of host fibroblasts into the bovine implant and the formation of endogenous types I and III collagen were demonstrated in all 29 cases. Adverse histological reactions were rare and, if present, they were predominantly of an inflammatory nature.
Frey
P
P
Department of Pediatric Surgery, CHUV, Lausanne, Switzerland.
Lutz
N
N
Berger
D
D
Herzog
B
B
D001672:Biocompatible Materials; D002114:Calcinosis / Q000209:etiology / Q000473:pathology; D003094:Collagen / Q000008:administration & dosage / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use*; D003432:Cross-Linking Reagents; D004724:Endoscopy; D005347:Fibroblasts / Q000473:pathology; D005549:Foreign-Body Reaction / Q000209:etiology / Q000473:pathology; D006801:Humans; D007249:Inflammation / Q000209:etiology / Q000473:pathology; D007267:Injections; D019736:Prostheses and Implants; D001743:Urinary Bladder; D014718:Vesico-Ureteral Reflux / Q000378:metabolism / Q000473:pathology / Q000628:therapy*
D001672:Biocompatible Materials; D003432:Cross-Linking Reagents; C048470:glutaraldehyde-cross-linked collagen; D003094:Collagen